Recruiting OBSERVATIONAL NCT03755726

A New Breath for Malignant Hypertension: Implementation of the HAMA Cohort (HAMA)

Sponsor: Centre Hospitalier de PAU

Updated 9 times since 2018 Last updated: Sep 26, 2024 Started: Sep 20, 2019 Primary completion: Sep 20, 2034 Completion: Sep 20, 2034

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03755726, this observational or N/A phase trial focuses on Malignant Hypertension and remains actively recruiting participants. Sponsored by Centre Hospitalier de PAU, it has been updated 9 times since 2019, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

9 versions recorded

Sep 2025 — Present [monthly]

Recruiting
Oct 2024 — Sep 2025 [monthly]

Recruiting
Sep 2024 — Oct 2024 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Sep 2022 — Jul 2024 [monthly]

Recruiting

▶ Show 4 earlier versions

Jan 2021 — Sep 2022 [monthly]

Recruiting
Nov 2019 — Jan 2021 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting
May 2019 — Nov 2019 [monthly]

Not Yet Recruiting
Dec 2018 — May 2019 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centre Hospitalier de PAU

Data source: Centre Hospitalier de PAU

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Annecy, France , Bayonne, France , Bobigny, France , Bordeaux, France , Chalon-sur-Saône, France , Chambéry, France , Clermont-Ferrand, France , Créteil, France , Dinard, France , Grenoble, France and 22 more locations